Cargando…
Correction to: Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884866/ https://www.ncbi.nlm.nih.gov/pubmed/33593400 http://dx.doi.org/10.1186/s13063-021-05109-8 |
Ejemplares similares
-
Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations
Publicado: (2021) -
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design
por: Angus, Derek C., et al.
Publicado: (2020) -
Strategies to Promote ResiliencY (SPRY): a randomised embedded multifactorial adaptative platform (REMAP) clinical trial protocol to study interventions to improve recovery after surgery in high-risk patients
por: Reitz, Katherine Moll, et al.
Publicado: (2020) -
Operationalisation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 trials in a low and lower-middle income critical care learning health system.
por: Aryal, Diptesh, et al.
Publicado: (2021) -
Adaptation of Saccadic Sequences with and without Remapping
por: Lévy-Bencheton, Delphine, et al.
Publicado: (2016)